Expanding the Benefit of Quality Improvement Programs: Sustainable Solutions to Achieve Therapeutic Goals for Patients with Myelofibrosis
| Overview / Abstract: |
Achieve measurable changes to improve your patients’ outcomes with this simple, systematic approach for quality improvement for application at any practice setting. Complete an assessment to understand where your practice’s performance falls relative to identified goals, which guides development of personalized action items. Access the framework and tools you need to measure your understanding. |
|
Expiration |
Oct 27, 2024 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME |
|
Format |
Online, Performance Improvement, Webinar / Webcast / Video |
|
Credits / Hours |
2.0 hours |
|
Accreditation |
ACCME, ABIM MOC Part IV, MIPS QPP |
|
Presenters / Authors / Faculty |
Brady Stein, MD, MHS |
|
Sponsors / Supporters / Grant Providers |
Provided by the Academy for Continued Healthcare Learning (ACHL). |
|
Keywords / Search Terms |
ACHL CME, CE, CTI Biopharma, Brady Stein, myelofibrosis, myeloproliferative, MF, risk assessment, neoplasm, coring system, community, academic, treatment selection, therapy selection, patient risk, evidence-based, rare, rarity, quality of life, MOC Part IV, MOC, ABIM, QPP, MIPS, QI, quality improvement Free CE CME |
|